Cargando…
Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
Purpose: To evaluate the efficacy of short-term low-dose quetiapine for delirium prevention in critically ill patients. Methods: In this prospective, a single-center, randomized, double-blind, placebo-controlled trial, adult patients who were admitted from July 2015 to July 2017 to a medical intensi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019813/ https://www.ncbi.nlm.nih.gov/pubmed/31892105 http://dx.doi.org/10.3390/jcm9010069 |
_version_ | 1783497606300696576 |
---|---|
author | Kim, Youlim Kim, Hyung-Sook Park, Jong Sun Cho, Young-Jae Yoon, Ho Il Lee, Sang-Min Lee, Jae Ho Lee, Choon-Taek Lee, Yeon Joo |
author_facet | Kim, Youlim Kim, Hyung-Sook Park, Jong Sun Cho, Young-Jae Yoon, Ho Il Lee, Sang-Min Lee, Jae Ho Lee, Choon-Taek Lee, Yeon Joo |
author_sort | Kim, Youlim |
collection | PubMed |
description | Purpose: To evaluate the efficacy of short-term low-dose quetiapine for delirium prevention in critically ill patients. Methods: In this prospective, a single-center, randomized, double-blind, placebo-controlled trial, adult patients who were admitted from July 2015 to July 2017 to a medical intensive care unit (ICU) of a tertiary teaching hospital affiliated to Seoul National University were included. Quetiapine (12.5 mg or 25 mg oral at night; N = 16) or placebo (N = 21) was administered according to randomization until ICU discharge or the 10th ICU day. The primary endpoint was the incidence of delirium within the first 10 ICU days. Secondary endpoints included the rate of positive Confusion Assessment Method for the ICU (CAM-ICU) (the number of positive CAM-ICU counts/the number of total CAM-ICU counts), delirium duration, successful extubation, and overall mortality. Result: The incidence of delirium during the 10 days after ICU admission was 46.7% (7/15) in the quetiapine group and 55.0% (11/20) in the placebo group (p = 0.442). In the quetiapine group, the rate of positive CAM-ICU was significantly lower than in the placebo group (14.4% vs. 37.4%, p = 0.048), delirium duration during the study period was significantly shorter (0.28 day vs. 1.83 days, p = 0.018), and more patients in the quetiapine than in the placebo group were weaned from mechanical ventilation successfully (84.6% vs. 47.1%, p = 0.040). Conclusions: Our study suggests that prophylactic use of low-dose quetiapine could be helpful for preventing delirium in critically ill patients. A further large-scale prospective study is needed. |
format | Online Article Text |
id | pubmed-7019813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70198132020-03-09 Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study Kim, Youlim Kim, Hyung-Sook Park, Jong Sun Cho, Young-Jae Yoon, Ho Il Lee, Sang-Min Lee, Jae Ho Lee, Choon-Taek Lee, Yeon Joo J Clin Med Article Purpose: To evaluate the efficacy of short-term low-dose quetiapine for delirium prevention in critically ill patients. Methods: In this prospective, a single-center, randomized, double-blind, placebo-controlled trial, adult patients who were admitted from July 2015 to July 2017 to a medical intensive care unit (ICU) of a tertiary teaching hospital affiliated to Seoul National University were included. Quetiapine (12.5 mg or 25 mg oral at night; N = 16) or placebo (N = 21) was administered according to randomization until ICU discharge or the 10th ICU day. The primary endpoint was the incidence of delirium within the first 10 ICU days. Secondary endpoints included the rate of positive Confusion Assessment Method for the ICU (CAM-ICU) (the number of positive CAM-ICU counts/the number of total CAM-ICU counts), delirium duration, successful extubation, and overall mortality. Result: The incidence of delirium during the 10 days after ICU admission was 46.7% (7/15) in the quetiapine group and 55.0% (11/20) in the placebo group (p = 0.442). In the quetiapine group, the rate of positive CAM-ICU was significantly lower than in the placebo group (14.4% vs. 37.4%, p = 0.048), delirium duration during the study period was significantly shorter (0.28 day vs. 1.83 days, p = 0.018), and more patients in the quetiapine than in the placebo group were weaned from mechanical ventilation successfully (84.6% vs. 47.1%, p = 0.040). Conclusions: Our study suggests that prophylactic use of low-dose quetiapine could be helpful for preventing delirium in critically ill patients. A further large-scale prospective study is needed. MDPI 2019-12-27 /pmc/articles/PMC7019813/ /pubmed/31892105 http://dx.doi.org/10.3390/jcm9010069 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Youlim Kim, Hyung-Sook Park, Jong Sun Cho, Young-Jae Yoon, Ho Il Lee, Sang-Min Lee, Jae Ho Lee, Choon-Taek Lee, Yeon Joo Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study |
title | Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study |
title_full | Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study |
title_fullStr | Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study |
title_full_unstemmed | Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study |
title_short | Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study |
title_sort | efficacy of low-dose prophylactic quetiapine on delirium prevention in critically ill patients: a prospective, randomized, double-blind, placebo-controlled study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019813/ https://www.ncbi.nlm.nih.gov/pubmed/31892105 http://dx.doi.org/10.3390/jcm9010069 |
work_keys_str_mv | AT kimyoulim efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT kimhyungsook efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT parkjongsun efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT choyoungjae efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT yoonhoil efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT leesangmin efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT leejaeho efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT leechoontaek efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy AT leeyeonjoo efficacyoflowdoseprophylacticquetiapineondeliriumpreventionincriticallyillpatientsaprospectiverandomizeddoubleblindplacebocontrolledstudy |